Genetics
Researchers from the United States and Canada provide details of new studies and findings in the area of genetics
Published in Gene Therapy Weekly, September 21st, 2006
Study 1: A study from the United States has reported on the clarification of the hepatic effects of flutamide (FLU).
"The antiandrogen FLU is used primarily for prostate cancer and is an idiosyncratic hepatotoxicant that sometimes causes severe liver problems. To investigate FLU's overt hepatic effects, especially on inducible drug clearance-related gene networks, FLU's hepatic gene expression profile was examined in female Sprague-Dawley rats using approximately 22,500 oligonucleotide microarrays," wrote K.J. Coe and colleagues, Amgen.
"Rats were dosed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-09-21)
More Articles from Gene Therapy Weekly
- Cardiology
Myofibril organization involves muscle-specific protein - Immunotherapy
Pneumocystis pneumonia host response requires chemokines - Lung Cancer
Lung cancer suppressed by RNA interference targeting pituitary transforming gene - Nephrology
Accelerated tubular cell aging occurs in senescence marker protein knockout mice - Neuroscience
Synaptotagmin silencing inhibits fast exocytosis and endocytosis - Allergy & Immunology
Myosin heavy chain phosphorylation coincides with mast cell degranulation - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
